Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
+0.49 (0.99%)
After Hours: 49.61 -0.14 (-0.28%)
Feb 24, 4:38PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 48.23 - 49.91
52 week 37.85 - 55.95
Open 48.91
Vol / Avg. 81,152.00/183,452.00
Mkt cap 1.11B
P/E 33.78
Div/yield 0.14/1.13
EPS 1.47
Shares 22.54M
Beta 0.88
Inst. own 103%
Jan 26, 2017
Q3 2017 Abaxis Inc Earnings Release (Estimated)
Nov 29, 2016
Abaxis Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 13.00% 14.20%
Operating margin 20.54% 21.18%
EBITD margin - 24.24%
Return on average assets 9.45% 11.50%
Return on average equity 10.74% 13.61%
Employees 549 -
CDP Score - -


3240 Whipple Rd
UNION CITY, CA 94587-1217
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Officers and directors

Clinton H. Severson Chairman of the Board, Chief Executive Officer
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald Peter Wood President, Chief Operating Officer
Age: 64
Bio & Compensation  - Reuters
Ross Taylor Chief Financial Officer, Vice President - Finance, Secretary
Age: 53
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 63
Bio & Compensation  - Reuters
Craig M. Tockman Vice President - Animal Health Sales and Marketing for North America
Age: 56
Bio & Compensation  - Reuters
Achim Henkel Managing Director of Abaxis Europe GmbH
Age: 58
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 71
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 70
Bio & Compensation  - Reuters
Henk J. Evenhuis Independent Director
Age: 73
Bio & Compensation  - Reuters